Cytosorbents Corporation Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 78.31. In total, the insiders bought 4 406 625 and sold 214 500 CTSO shares in the last 100 trades.

Insider Power

(Last 100 transactions)
78.31
Buy 4 406 625 Shares
Sell 214 500 Shares

Historical Insider Trades

Date Type Action Person Amount
Apr 02, 2024 Stock Option (Right to Buy) Buy Jones Edward Raymond 22 000
Apr 02, 2024 Common Stock Buy Deliargyris Efthymios 61 000
Apr 02, 2024 Stock Option (Right to Buy) Buy Deliargyris Efthymios 86 000
Apr 02, 2024 Stock Option (Right to Buy) Buy Sobel Alan D. 22 000
Apr 02, 2024 Common Stock Buy Bloch Kathleen P. 65 000
Apr 02, 2024 Stock Option (Right to Buy) Buy Bloch Kathleen P. 87 000
Apr 02, 2024 Stock Option (Right to Buy) Buy Bator Michael G. 44 000
Apr 02, 2024 Common Stock Buy Capponi Vincent 81 000
Apr 02, 2024 Stock Option (Right to Buy) Buy Capponi Vincent 101 000
Apr 02, 2024 Stock Option (Right to Buy) Buy Kim Jiny 22 000
Apr 02, 2024 Common Stock Buy Chan Phillip P. 96 000
Apr 02, 2024 Stock Option (Right to Buy) Buy Chan Phillip P. 124 000
Mar 29, 2024 Stock Option (Right to Buy) Buy Deliargyris Efthymios 47 088
Mar 29, 2024 Stock Option (Right to Buy) Buy Capponi Vincent 48 923
Mar 29, 2024 Stock Option (Right to Buy) Buy Bloch Kathleen P. 49 038
Mar 29, 2024 Stock Option (Right to Buy) Buy Chan Phillip P. 129 998
Dec 13, 2023 Common Stock Buy Sobel Alan D. 22 557
Dec 13, 2023 Common Stock Warrant (Right to Buy) Buy Sobel Alan D. 7 894
Dec 13, 2023 Common Stock Buy Deliargyris Efthymios 22 557
Dec 13, 2023 Common Stock Warrant (Right to Buy) Buy Deliargyris Efthymios 7 894
Dec 13, 2023 Common Stock Buy Capponi Vincent 18 797
Dec 13, 2023 Common Stock Warrant (Right to Buy) Buy Capponi Vincent 6 578
Dec 13, 2023 Common Stock Buy Bator Michael G. 37 594
Dec 13, 2023 Common Stock Warrant (Right to Buy) Buy Bator Michael G. 13 157
Dec 13, 2023 Common Stock Buy Jones Edward Raymond 7 519
Click to get the best stock tips daily for free!

About Cytosorbents Corporation

Cytosorbents Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention and treatment of perioperative complication... CTSO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT